{
  "title": "Learning to Love Big Pharma",
  "itunes:title": "Learning to Love Big Pharma",
  "description": "<p>Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:season": 5,
  "itunes:episode": 68,
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "ef8a1b30-ba4d-11ea-a5ae-0745d28f3213",
  "omny:clipId": "f12f184c-b83d-4020-bce5-ae390093e759",
  "pubDate": "Mon, 29 Jun 2020 21:26:02 +0000",
  "itunes:duration": 807,
  "enclosure": "",
  "link": "https://omny.fm/shows/prognosis-breakthrough/learning-to-love-big-pharma"
}